Navigation Links
Ovary Removal Lowers Odds of Cancer in High-Risk Women
Date:1/13/2009

Study confirms women with BRCA mutations are wise to take preventive action

TUESDAY, Jan. 13 (HealthDay News) -- Removing the ovaries of women with a high risk of breast and ovarian cancer due to mutations in BRCA1 or BRCA2 genes does substantially reduce their risk of getting both cancers, a new study confirms.

Researchers from the University of Pennsylvania School of Medicine and Memorial Sloan-Kettering Cancer Center did what's known as a meta-analysis, pooling the results of several studies and re-analyzing them. Led by Dr. Timothy Rebbeck, a professor of epidemiology at the university, the research team looked at 10 published studies. The report appears in the Jan. 13 issue of the Journal of the National Cancer Institute.

The risk reduction, he said, is substantial but perhaps not as high as earlier studies have suggested.

But not everyone agrees with that assessment. An expert who reviewed the study said the actual risk reduction may be higher than Rebbeck's team found because surgical techniques and preventive approaches have improved since some of the studies they analyzed were done.

Rebbeck said that "the earlier studies in this area were suggesting something like a 95 percent risk reduction, a near complete reduction [in ovarian cancer risk] that was very encouraging." But his team found somewhat less of a risk reduction with the procedure that involves removing the ovaries and fallopian tubes, called a prophylactic salpingo-oophorectomy. They found a 79 percent reduced risk of ovarian cancer and a 51 percent reduced risk of breast cancer.

"The breast cancer number has been pretty consistent throughout history," Rebbeck said.

Women who have inherited mutations in the BRCA1 or BRCA2 genes have elevated risks of both breast and ovarian cancer. The lifetime risk of breast cancer ranges from 56 percent to 84 percent, according to the researchers, whereas the risk for ovarian cancer ranges from 36 percent to 46 percent for BRCA1 mutation carriers and 10 percent to 27 percent for BRCA2 mutation carriers.

Women with these gene mutations usually are counseled to help them choose strategies to reduce the risk, which might include removing the ovaries or breasts, as well as screening and other prevention techniques.

But even removal of the ovaries cannot guarantee that a woman will never get ovarian cancer, Rebbeck said. Sometimes, for instance, ovarian cells get left behind in the surgery, he explained.

Dr. Jeffrey N. Weitzel, chief of the division of clinical cancer genetics at the City of Hope Comprehensive Cancer Center in Duarte, Calif., said pooling the results of 10 studies provided "enough [statistical] power to have a strong observation of a beneficial effect for BRCA1 and BRCA2 carriers."

By combining studies, "we get greater confidence there is a high likelihood this is a real effect," he said.

But in reality, a woman undergoing preventive removal of the ovaries today would probably have "closer to a 90 percent" reduction in ovarian cancer risk, Weitzel estimated. That's because, he said, the surgery that's done now is more thorough than it was in years past.

For women who are BRCA1 or BRCA2 carriers, preventive ovary removal is often recommended at age 35 or after completion of childbearing, Rebbeck said. Another way to reduce risk would be for a woman to go on oral contraceptives in her 20s, before childbearing, he said.

More information

To learn more about the risk factors for ovarian cancer, visit the American Cancer Society.



SOURCES: Timothy Rebbeck, Ph.D., professor, epidemiology, University of Pennsylvania School of Medicine, Philadelphia; Jeffrey N. Weitzel, M.D., chief, division of clinical cancer genetics, and professor, oncology and population science, City of Hope Comprehensive Cancer Center, Duarte, Calif.; Jan. 13, 2009, Journal of the National Cancer Institute, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. SurgiQuest Announces First Single Port Procedure for Uterus and Ovary Removal Using AirSeal(TM) Access System
2. Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
3. Ovary Removal Protects Some High-Risk Women
4. Hair Removal Forum Unveils New Doctor Finder Interface
5. Laser Beam Beauty: 'The Complete Guide to Laser Hair Removal' DVD released by Aesthetic VideoSource
6. Study Evaluates Laser Therapies for Hair Removal
7. Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. Latest Laser Fat Removal Procedure Now Available
10. TRIA Personal Laser Hair Removal System Now Available at Aesthetic Physician Offices
11. Virtual biopsy can tell whether colon polyp is benign without removal, Mayo researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ovary Removal Lowers Odds of Cancer in High-Risk Women
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis ... (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the report ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... On the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach ... works! , Countless deodorants flood the aisles that contain harmful chemicals that should ...
(Date:4/27/2017)... ... April 27, 2017 , ... Last night, ... CAREGiverSM of the Year for her extraordinary compassion and lifelong dedication to serve ... American professional caregivers for the prestigious award each year – identifying a CAREGiver ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology: